Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

22nd Century Group Inc (XXII)

22nd Century Group Inc (XXII)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 102,629
  • Shares Outstanding, K 138,857
  • Annual Sales, $ 25,830 K
  • Annual Income, $ -26,560 K
  • 60-Month Beta 1.54
  • Price/Sales 4.12
  • Price/Cash Flow N/A
  • Price/Book 1.55
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.20
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/05/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6000 +23.18%
on 03/12/20
0.8900 -16.96%
on 03/05/20
-0.0912 (-10.98%)
since 02/27/20
3-Month
0.6000 +23.18%
on 03/12/20
1.2000 -38.41%
on 02/12/20
-0.4009 (-35.17%)
since 12/27/19
52-Week
0.6000 +23.18%
on 03/12/20
2.4600 -69.96%
on 09/27/19
-0.9709 (-56.78%)
since 03/27/19

Most Recent Stories

More News
22nd Century Group, Inc. Files 2019 Annual Report

22nd Century Group, Inc. (NYSE American: XXII), a leading plant biotechnology company in reduced nicotine tobacco and hemp/cannabis plant genetics research and development, yesterday filed its Annual Report...

XXII : 0.7391 (-3.55%)
22nd Century Announces Important New Achievements with KeyGene

Delivers Complete High-Quality Hemp/Cannabis Genome Sequence; Establishes New Proprietary Hemp/Cannabis Bioinformatics Platform

XXII : 0.7391 (-3.55%)
22nd Century Group Adds to Leadership Team

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant genetics research, today announced the appointment of...

XXII : 0.7391 (-3.55%)
CORRECTION: Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use of Very Low Nicotine Content Cigarettes Does Not Lead to Compensatory Smoking

22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant research, announced that two studies published in Cancer...

XXII : 0.7391 (-3.55%)
Further Support for Reducing Nicotine in Cigarettes to Non-Addictive Levels: New Studies Confirm Use

22nd Century Group, Inc. (NYSE AMERICAN: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant research, announced that two studies published in Cancer...

XXII : 0.7391 (-3.55%)
FDA Scientific Advisory Committee Discusses 22nd Century Group's Reduced Nicotine Cigarettes

22nd Century Group, Inc. (NYSE American: XXII) -- a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant research -- met on Friday, February 14, 2020 with the...

XXII : 0.7391 (-3.55%)
22nd Century Group's FDA Advisory Committee Meeting for Reduced Nicotine Content Cigarettes Brings New Standard for the Tobacco Industry

22nd Century Group, Inc. (NYSE American: XXII)--a plant biotechnology company that is a leader in tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis plant research--will present the Company's...

XXII : 0.7391 (-3.55%)
22nd Century Group Appoints New Director and New Chairman

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis research, announced...

XXII : 0.7391 (-3.55%)
RAND : 2.05 (-2.15%)
22nd Century Group to Present its Modified Risk Tobacco Product Application to FDA's Tobacco Products Scientific Advisory Committee

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco and hemp/cannabis research, announced...

XXII : 0.7391 (-3.55%)
FDA Authorizes Marketing of 22nd Century Group's Proprietary Moonlight(R) and Moonlight(R) Menthol Cigarettes

22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, Very Low Nicotine Content (VLNC) tobacco, and hemp/cannabis plant research, announced...

XXII : 0.7391 (-3.55%)
PM : 69.15 (-2.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade XXII with:

Business Summary

22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products...

See More

Key Turning Points

2nd Resistance Point 0.8271
1st Resistance Point 0.7831
Last Price 0.7391
1st Support Level 0.7019
2nd Support Level 0.6647

See More

52-Week High 2.4600
Fibonacci 61.8% 1.7495
Fibonacci 50% 1.5300
Fibonacci 38.2% 1.3105
Last Price 0.7391
52-Week Low 0.6000

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar